未登录

N

Nicola Salvatore Orefice

amsterdam neuroscience

H指数:13

被引数:471

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinctive characteristics of dopamine neuron release mechanisms: Insights into Parkinson’s Disease

多巴胺神经元释放机制的独特特征：对帕金森病的见解

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2026-05-280

OAAI

PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis

PAD2介导的MBP瓜氨酸化及多发性硬化中髓鞘的早期不稳定化

Journal of Autoimmunity

IF7

2026-05-150

OAAI

Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review

EXPERT OPINION ON THERAPEUTIC PATENTS

IF4.6

2023-03-2731

OA

Cerebral phospho-tau acts synergistically with soluble Aβ42 leading to Mild Cognitive Impairment in AAV-AD rats (vol 9, pg 480, 2022)

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE

IF7.8

2023-01-010

OA

Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE

IF7.8

2022-07-017

OAAI

Cerebral phospho-tau acts synergistically with soluble Aβ42 leading to Mild Cognitive Impairment in AAV-AD rats (Jan, 10.14283/jpad.2022.18, 2022)

JOURNAL OF NUTRITION HEALTH & AGING

IF4

2022-04-010

OA

Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE

IF7.8

2022-04-015

OAAI

Chemically Modified Extracellular Vesicles and Applications in Radiolabeling and Drug Delivery

IF5.5

2022-03-1616

OAAI

Increased expression of SLC25A1/CIC causes an autistic-like phenotype with altered neuron morphology

IF11.7

2022-02-2514

OA

SLC13A5/sodium-citrate co-transporter overexpression causes disrupted white matter integrity and an autistic-like phenotype

BRAIN COMMUNICATIONS

IF4.5

2022-01-0511

OA

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions

IF0

2020-09-1711

OA

Integrated Label-Free and 10-Plex DiLeu Isobaric Tag Quantitative Methods for Profiling Changes in the Mouse Hypothalamic Neuropeptidome and Proteome: Assessment of the Impact of the Gut Microbiome

ANALYTICAL CHEMISTRY

IF6.7

2020-09-1418

OAAI

Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice

ACTA NEUROPATHOLOGICA COMMUNICATIONS

IF5.7

2019-03-1834

OAAI

Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis

NEUROTHERAPEUTICS

IF6.9

2016-04-0146

OAAI

The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells

BRAIN RESEARCH BULLETIN

IF3.7

2015-09-0113

PREAI

Galactosyl prodrug of palmitoylethanolamide: Synthesis, stability, cell permeation and cytoprotective activity

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2014-10-014

PREAI

N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress

PHARMACOLOGICAL RESEARCH

IF10.5

2013-10-0136

PRE

Necrotizing skin lesion and radial nerve palsy in a patient treated with glatiramer acetate

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2013-08-015

PREAI